Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection
Johannes F. Fahrmann(The University of Texas MD Anderson Cancer Center), Samir Hanash(The University of Texas MD Anderson Cancer Center), Jeanine M. Genkinger(Columbia University Irving Medical Center), Lauren K. Brais(Dana-Farber Cancer Institute), Ana Babić(Dana-Farber Brigham Cancer Center), Fay Kastrinos(Columbia University Irving Medical Center), Kunal Jajoo(Harvard University), Maureen Loftus(Dana-Farber Brigham Cancer Center), Brian M. Wolpin(Harvard University), Anirban Maitra(NYU Langone Health), Kim‐Anh Do(The University of Texas MD Anderson Cancer Center), Michele Yip-Schneider(Indiana University – Purdue University Indianapolis), James P. Long(The University of Texas MD Anderson Cancer Center), John A. Chabot(Columbia University Irving Medical Center), Andrea J. Bullock(Beth Israel Deaconess Medical Center), Linda Lee(Purdue University West Lafayette), Kimmie Ng(Dana-Farber Cancer Institute), Michael D. Kluger(Columbia University Irving Medical Center), Jianjun Zhang(Indiana University Health), Jennifer B. Dennison(The University of Texas MD Anderson Cancer Center), Jody Vykoukal(The University of Texas MD Anderson Cancer Center), Thomas E. Clancy(Brigham and Women's Hospital), Xiangying Mao(The University of Texas MD Anderson Cancer Center), Jinming Zhang(Ipsen (United States)), Ehsan Irajizad(The University of Texas MD Anderson Cancer Center), Nikul Patel(The University of Texas MD Anderson Cancer Center), C. Max Schmidt(Indiana University School of Medicine)
Cited by 199
Related Papers
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k